Pfizer and FDA delay rollout of COVID-19 vaccines for kids younger than 5

COVID-19 vaccines will not be available for kids younger than 5 in the coming weeks, as some had hoped. Instead of approving a two-dose vaccine for the age group and approving a third one if necessary after the fact as planned, Pfizer-BioNTech and the Food and Drug Administration will wait until April, when the pharmaceutical company says its study on a third dose for young children will be complete.

Leave a Reply